MedMira Inc.
MIR.V
TSX
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -17.45% | -5.53% | -28.33% | -47.35% | -53.31% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -17.45% | -5.53% | -28.33% | -47.35% | -53.31% |
| Cost of Revenue | 12.76% | 17.24% | -0.28% | -21.55% | -34.15% |
| Gross Profit | -40.50% | -39.88% | -37.50% | -29.93% | -5.71% |
| SG&A Expenses | 30.32% | 40.72% | 14.16% | 73.06% | 40.97% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 35.83% | 24.05% | 2.81% | 8.34% | -3.06% |
| Operating Income | -47.01% | -30.63% | -11.40% | -34.94% | -25.26% |
| Income Before Tax | -34.70% | -22.48% | -41.24% | -42.39% | -37.03% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -34.70% | -22.48% | -41.24% | -42.39% | -37.03% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -34.70% | -22.48% | -41.24% | -42.39% | -37.03% |
| EBIT | -47.01% | -30.63% | -11.40% | -34.94% | -25.26% |
| EBITDA | -49.60% | -32.94% | -12.10% | -38.99% | -28.61% |
| EPS Basic | -37.93% | -21.43% | -39.13% | -36.36% | -31.82% |
| Normalized Basic EPS | -38.89% | -29.41% | -42.86% | -46.15% | -38.46% |
| EPS Diluted | -21.62% | -2.70% | -26.67% | -32.14% | -37.04% |
| Normalized Diluted EPS | -38.89% | -29.41% | -42.86% | -46.15% | -38.46% |
| Average Basic Shares Outstanding | 0.48% | 0.33% | 0.18% | 0.02% | 0.00% |
| Average Diluted Shares Outstanding | 0.48% | 0.33% | 0.18% | 0.02% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
